Ongoing protocols: click on the protocol for the inclusion and exclusion criteria (update 31/05/2019)

1ste line
Currently no trials

2nd line 
Currently no trials

New trial in start-up: BEAT: Atezolizumab plus Bevacizumab and standard chemotherapy versus Bevacizumab and standard chemotherapy in 1st line.